スポロゾイト表面タンパク質2とCSタンパク質を併用したワクチンによるマラリア予防
S Khusmith1, Y Charoenvit, S Kumar
1Malaria Program, Naval Medical Research Institute, Bethesda, MD 20889.
まとめ
完全なマラリアスポロゾイトワクチンの開発には,複数の抗原をターゲットにする必要があります. ワクチン投与システムで,サーキムスポロゾイト (CS) タンパク質とスポロゾイト表面タンパク質2 (SSP2) を組み合わせることで,マウスで完全な保護が得られました.
科学分野:
- 免疫学 免疫学とは
- ワクチン学 ワクチン学
- 感染症 感染症は感染症です.
背景:
- 環球胞子 (CS) タンパク質は,マラリア胞子ワクチン開発の主要な標的である.
- CSタンパク質のみに基づくサブユニットワクチンは,完全な保護を達成していません.
- 放射線被曝されたスポロゾイト免疫は,強力な保護免疫を誘発する.
研究 の 目的:
- Plasmodium yoelii sporozoitesを標的としたマルチアンチゲンワクチンの有効性を調査する.
- 防護免疫におけるスポロゾイト表面タンパク質2 (SSP2) の役割を評価する.
- シングル抗原対マルチ抗原ワクチンによって誘発される保護を比較する.
主な方法:
- BALB/cマウスの免疫は,放射線を受けたPlasmodium yoelii sporozoitesで実施した.
- CSタンパク質とSSP2.2に対する抗体と細胞毒性T細胞の生成.
- P815細胞をSSP2とCSの免疫用遺伝子で感染させる.
- マラリアに対する保護を評価するための研究に挑戦する.
主要な成果:
- 照射されたスポロゾイト免疫はSSP2.2に対する抗体と細胞毒性T細胞を誘発した.
- SSP2またはCSトランスフェクタントで免疫されたマウスは,部分的な保護を示しました.
- SSP2とCSトランスフェクタントの混合物で免疫を施したマウスでは完全な保護が達成されました.
結論:
- ワクチン接種システムは,マラリアに対する完全な保護を達成するために不可欠です.
- SSP2とCSタンパク質の両方を標的にするマルチ抗原スポロゾイトワクチンは有効です.
- これらの発見は,複数のスポロゾイト抗原に基づいた新しいマラリアワクチンの開発を支援します.
関連する概念動画
Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Diversity of Protists II
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...


